These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 807729)

  • 81. Degradation of circulating DNA by extracorporeal circulation over nuclease immobilized on nylon microcapsules.
    Terman DS; Tavel A; Tavel T; Petty D; Harbeck R; Buffaloe G; Carr R
    J Clin Invest; 1976 May; 57(5):1201-12. PubMed ID: 1262466
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Passive hemagglutination and hemolysis tests for the detection of anti-DNA antibody.
    Sasaki T; Ishida S; Onodera S; Saito T; Furuyama T; Yoshinaga K
    J Immunol Methods; 1978; 22(3-4):327-37. PubMed ID: 355555
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Production of antibodies specific for double stranded antigen DNA cloned from immune complexes in plasma of a SLE patient.
    Terada K; Hirose S; Okuhara E
    Biochem Biophys Res Commun; 1992 Mar; 183(2):797-802. PubMed ID: 1550584
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Autoimmunity, immune complexes, DNA, and SLE.
    Marmont AM
    Lancet; 1980 May; 1(8177):1088. PubMed ID: 6103423
    [No Abstract]   [Full Text] [Related]  

  • 85. Disparity between humoral and cellular immune responses to desoxyribonucleic acid in systemic lupus erythematosus.
    Hahn BH; Bagby MK; Osterland CK
    Am J Med Sci; 1973 Sep; 266(3):193-201. PubMed ID: 4583410
    [No Abstract]   [Full Text] [Related]  

  • 86. Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study.
    Füst G; Kavai M; Szegedi G; Meretey K; Falus A; Lenkey A; Misz M
    J Immunol Methods; 1980; 38(3-4):281-9. PubMed ID: 7440977
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proceedings: Circulating complexes and disease activity in SLE.
    Bruneau C; Edmonds JP; Hughes GR
    Ann Rheum Dis; 1975 Oct; 34(5):469. PubMed ID: 1221935
    [No Abstract]   [Full Text] [Related]  

  • 88. Splenic function in non-renal systemic lupus erythematosus.
    Elkon KB; Sewell JR; Ryan PF; Hughes GR
    Am J Med; 1980 Jul; 69(1):80-2. PubMed ID: 7386513
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis.
    Eilat D
    Immunol Today; 1985 Apr; 6(4):123-7. PubMed ID: 25289497
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Characteristic differences in inhibitory effects of oligodeoxyribonucleotides from DNA on human systemic lupus erythematodes (SLE) sera and rabbit anti-DNA sera.
    Wakizaka A; Okuhara E
    Tohoku J Exp Med; 1977 Jun; 122(2):161-6. PubMed ID: 70086
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.
    Adler MK; Baumgarten A; Hecht B; Siegel NJ
    Ann Rheum Dis; 1975 Oct; 34(5):444-50. PubMed ID: 1221925
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid.
    Keeffe EB; Bardana EJ; Harbeck RJ; Pirofsky B; Carr RI
    Ann Intern Med; 1974 Jan; 80(1):58-9. PubMed ID: 4855719
    [No Abstract]   [Full Text] [Related]  

  • 93. Differentiation of specific DNA binding activity of SLE sera from non-specific binding by an addition of dextran sulfate and calcium chloride to the Farr assay system.
    Kashimura M; Wakizaka A; Kurosaka K; Okuhara E; Akihama T; Miura AB; Shibata A
    Tohoku J Exp Med; 1981 Aug; 134(4):357-65. PubMed ID: 6172885
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A new DNA immune adsorbent for hemoperfusion in SLE therapy: a clinical trial.
    Yang Y; Yu YT; Song JC; Qian SC; Quan WL; Shao XH; Cui RH; Wang JZ
    Artif Organs; 1988 Oct; 12(5):444-6. PubMed ID: 3190494
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fibrinogen catabolism in systemic lupus erythematosus.
    Sergent JS; Sherman RL; Al-Mondhiry H
    Arthritis Rheum; 1976; 19(2):195-8. PubMed ID: 1259800
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunology of DNA. IV. Quantitative aspects of the Farr assay.
    Aarden LA; Lakmaker F; De Groot ER
    J Immunol Methods; 1976; 11(2):153-63. PubMed ID: 932447
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Anti-lymphocyte antibodies in the pathogenesis of SLE.
    Searles RP; Williams RC
    Clin Exp Rheumatol; 1986; 4(2):175-82. PubMed ID: 3524939
    [No Abstract]   [Full Text] [Related]  

  • 98. Demonstration of extrinsic DNA from immune complexes in plasma of a patient with systemic lupus erythematosus.
    Terada K; Okuhara E; Kawarada Y; Hirose S
    Biochem Biophys Res Commun; 1991 Jan; 174(1):323-30. PubMed ID: 1989612
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system.
    Seibold JR; Buckingham RB; Medsger TA; Kelly RH
    Semin Arthritis Rheum; 1982 Aug; 12(1):68-76. PubMed ID: 7134990
    [No Abstract]   [Full Text] [Related]  

  • 100. Characteristics of pathogenic subpopulations of antibodies to DNA.
    Hahn BH
    Arthritis Rheum; 1982 Jul; 25(7):747-52. PubMed ID: 7104052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.